PSA Today Nov 25: Dampened by profit-taking / Aska Pharmaceutical: promising developments / Diamond's exciting EV business / Fuji Soft gets Blue Prism's Silver rating – Nikkei +0.50%
Japan Market Comment by Pelham SmithersNikkei ¥26,296.86 (+¥131.27 / +0.50%); Topix ¥1,767.67 (+¥5.27 / +0.30%); ¥/$104.41
Tags: Nissan Motor (7201 JT), Z Holdings (4689 JT), Nippon Steel (5401 JT), Mitsubishi Motors (7211 JT), Panasonic (6752 JT), Nidec (6594 JT) Rohm (6963 JT), Molitec Steel (5986 JT), Diamond Electric (6699 JT), Sony (6758 JT), SBI Holdings (8473 JT), Ripple, Aska Pharmaceutical (4514 JT), Fuji Soft Inc (9749 JT), Blue Prism (PRSM LN), Microsoft (MSFT US), RPA Holdings (6572 JT), NTT Data (9613 JT), UiPath, Automation Anywhere, NEC (6701 JT)
Main Points
• Profit-taking dampens performance after strong opening
• Aska’s relugolix meets Phase III endpoint for endometriosis
• Diamond updates on its EV business
• Fuji Soft acquires Blue Prism’s Silver rating
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.